Thu, Jul 24, 2014, 7:07 AM EDT - U.S. Markets open in 2 hrs 23 mins

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kaylawa kaylawa Sep 18, 2012 12:15 PM Flag

    AMRN at AMCP's Educational Conference Oct 3-5, 2012 (managed care)

    Here's their listing of types of attendees:

    Managed Care Executives
    Pharmacy Directors
    Medical Directors
    Academia
    Professional Relations
    Outcomes Research Professionals
    Medical Affairs Pharmacist
    Clinical Coordinators
    Case Managers/RNs
    Residents and Fellows
    Student Pharmacists

    And here's an example from the schedule. AMRN will also participate in The Exchange (see above post):

    11:30 am - 12:00 pm Purdue Pharma L.P.
      Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need
      Diagnosis and appropriate management of insomnia are important aspects of patient care. Attend the Purdue Pharma L.P. Product Theater “Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need” to learn about a treatment option now available.
    Speaker: Russell Rosenberg, PhD
       
    11:30 am - 12:00 pm Forest Pharmaceuticals, Inc.
      This program will evaluate the impact of COPD, review the 2011 GOLD guidelines, discuss goals for improving lung function and present a treatment option for the management of COPD.
    Speaker: Shari Fine, DO
       
    12:15 pm - 12:45 pm VIVUS, Inc.
      A New Once-Daily Treatment for Obesity
      This program will evaluate the impact of obesity on related risk factors and discuss the clinical guidelines and evolving treatment landscape in obesity.
    Speaker: Barbara Troupin, MD, MBA
       
    12:15 pm - 12:45 pm AMARIN
      Vascepa™: A new therapy for the treatment of severe hypertriglyceridemia
       
    Friday, October 5th

     
       
    8:30 am - 9:00 am Pfizer Inc
      Neuropathic Pain Associated with Spinal Cord Injury
      This 30-minute presentation will focus on characterization of neuropathic pain associated with spinal cord injury and its personal and societal burden. Dr. Liss will present clinical trial data and important managed care perspectives. This presentation will include a question-and answer session.
    Speaker:
    Jonathan L. Liss, MD
    Medical Director
    Muscogee Manor & Rehabilitation Center
    Columbus, GA

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.580.00(0.00%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT